Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Pediatric Hematology
•
Benign Hematology
•
Eosinophilia
•
Pediatric Oncology
•
Oncology
How would you manage moderate eosinophilia (~2-3k) with no evidence of end organ damage?
Related Questions
How would you manage HHT with ongoing epistaxis despite IV bevacizumab, with a history of superficial thrombosis?
What is your approach to patients/parents seeking alternative or complementary treatment in pediatric oncology patients?
Which oral chemotherapy regimen do you use in relapsed fusion positive rhabdomyosarcoma?
Do you use prophylactic defibrotide in pediatric patients undergoing BMT who are considered to be at high risk for the development of VOD/SOS?
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
What experience have you had with familial clustering of polycythemia vera?
What is your preferred strategy for young adults with ITP complicated by recurrent autoimmune neutropenia?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
How would you manage aplastic anemia refractory to multiple agents?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
